Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19
Clinical trial NCT04549922 · COMPLETED
Trial details
- NCT number
- NCT04549922
- Sponsor
- Hospital do Coracao
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2020-12-09
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.